R1 RCM Surges After TCP-ASC Says It's in the Process of Finalizing Deal Proposal
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)
Buy Rating on R1 RCM Amid Acquisition Interest and Market Undervaluation
A Quick Look at Today's Ratings for R1 RCM(RCM.US), With a Forecast Between $14 to $20
On Jul 03, major Wall Street analysts update their ratings for $R1 RCM(RCM.US)$, with price targets ranging from $14 to $20.Morgan Stanley analyst Craig Hettenbach maintains with a buy rating, and mai
New Mountain Capital Proposes Buyout of R1 RCM
By Colin Kellaher Private-equity firm New Mountain Capital has submitted a bid to buy R1 RCM in a deal that values the revenue-cycle-management provider at around $5.58 billion. New Mountain, which
Buy Rating Affirmed for R1 RCM on Market Leadership and AI Growth Prospects
Sector Update: Financial Stocks Rise in Afternoon Trading
Financial stocks were advancing in Tuesday afternoon trading, with both the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) adding 0.5%. The Philadelphia Housing Index was falling
Stocks Hold Steady As Powell Reassures On Disinflation Path, Warns About Debt Risks; Tesla Rallies, Job Openings Spike: What's Driving Markets Tuesday?
U.S. equities were little moved on Tuesday as investors continued to assess the potential for interest rate cuts following the latest economic data and comments from Fed Chair Jerome Powell.Speaking a
R1 RCM Is Maintained at Outperform by Baird
R1 RCM Is Maintained at Outperform by Baird
Express News | Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target
R1 RCM Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 85.92% Cantor Fitzgerald $20 → $20 Reiterates Overweight → Overweight 06/28/2024 76.62% RBC Cap
R1 RCM Down Over 14%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk
R1 RCM Inc (RCM) is currently at $10.76, down $1.80 or 14.29% --Would be lowest close since Feb. 21, 2024, when it closed at $10.68 --On pace for largest percent decrease since Nov. 8, 2022, when it
R1 RCM Shares Fall After New Mountain Lowers Takeover Offer
R1 RCM (RCM) shares were down by more than 14% in recent Tuesday trading after New Mountain Capital said it is no longer interested in pursuing a joint acquisition of R1 with TCP-ASC and lowered its p
R1 RCM Shares Slide on Reduced Hopes for Buyout Deal
By Colin Kellaher R1 RCM shares fell nearly 15% Tuesday after the revenue-cycle-management company's two biggest shareholders couldn't reach an agreement on a joint buyout bid. Private-equity firm N
Assessing R1 RCM's Value Amidst Transaction Uncertainty and Client Challenges: A 'Buy' Rating Justification
Evercore Maintains R1 RCM(RCM.US) With Hold Rating, Maintains Target Price $14
Evercore analyst Elizabeth Anderson CFA maintains $R1 RCM(RCM.US)$ with a hold rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 37.6% and a t
Market-Moving News for July 2nd
RDZN: 81% | Roadzen shares are trading higher following FY24 earnings.RCM: -10% | R1 RCM shares are trading lower after the company announced that discussions have not resulted in any agreement and Ne
Evercore ISI Remains a Hold on R1 RCM (RCM)
Express News | R1 RCM Shares Are Trading Lower After the Company Announced That Discussions Have Not Resulted in Any Agreement and New Mountain Capital Is No Longer Interested in Pursuing a Joint Proposal With TCP-ASC
Truist Financial Maintains R1 RCM(RCM.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $R1 RCM(RCM.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 29.9% and a total average return of -16.2% over the